Clinical Trials

Company-Supported Clinical Trials

Key clinical trials sponsored by Mallinckrodt for branded drugs are listed on www.clinicaltrials.gov and detailed below, with a link provided to learn more and an indicator of the current phase of development.

Study TitlePHASE
1
PHASE
2
PHASE
3
PHASE
4
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin (CONFIRM)
More Information (MNK19013058) >
    X  
A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular Dystrophy (BRAVE)
More Information (MNK14112096) >
  X    
Acthar for Treatment-Resistant or Treatment-Intolerant Proteinuria (PODOCYTE)
More Information (MNK14224049) >
      X
Acthar Gel for Active Systemic Lupus Erythematosus (SLE)
More Information (MNK14304067) >
      X
Acthar Gel in Participants With Pulmonary Sarcoidosis (PULSAR)
More Information (MNK14344100) >
      X
ExpressGraft-C9T1 Skin Tissue as a Treatment of Diabetic Foot Ulcers
More Information (CPT12015) >
X      
Adrabetadex for Patients With Nerve Symptoms of Niemann-Pick Type C Disease (NPC)
More Information (VTS-270-001) >
    X  
Follow up Study of Patients Having Participated in Clinical Trial 64,185-204 (JASMINE_205)
More Information (64,185-205) >
       
Impact of Acthar on Everyday Life of Participants With Severe Keratitis
More Information (MNK14084113) >
      X
MNK-6105 for Patients With Cirrhosis and High Ammonia Levels Affecting Brain Function
More Information (MNK61053106) >
    X  
MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)
More Information (MNK61062107) >
  X    
Multiple Applications of ExpressGraft-C9T1 Skin Tissue as a Treatment for Diabetic Foot Ulcers
More Information [C9T12015 (Extended)] >
X      
Open-label Study of VTS-270 in Participants With Neurologic Manifestations of Niemann-Pick Type C1
More Information (VTS-270-302) >
  X X  
Pilot Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in Subjects With Relapsing-Remitting Multiple Sclerosis (OPTIONS)
More Information (MNK14274069) >
      X
Registry to Evaluate INOmax in Newborn Babies with Pulmonary Hypertension (PaTTerN)
More Information (MNK19050056) >
      X
Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer)
More Information (MNK61074105) >
      X
StrataGraft® Skin Tissue in the Promotion of Autologous Skin Regeneration of Complex Skin Defects Due to Thermal Burns That Contain Intact Dermal Elements
More Information (STRATA2016) >
    X  
VTS-270 to Treat Niemann-Pick Type C1 (NPC1) Disease
More Information (VTS301) >
  X X